Polyphenol-konjugiertes Nanokreibersystem verbessert Antikörpertherapien bei Brustkrebs

Researchers in Japan created PEGylated polyphenol nanocarriers that deliver antibodies into breast cancer cells by escaping endosomes, restoring p53 activity, reducing tumors by 80%, and showing minimal toxicity—advancing targeted intracellular cancer therapy.